← SynDRA
EVATANEPAG
SynDRA canonical compound SYN0019530 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PTGER2 | PTGER4 |
|---|
| Mechanism of action | prostaglandin inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PTGER2 AGONIST
- Prostanoid EP2 receptor agonist
- PTGER4 ANTAGONIST
- prostaglandin inhibitor
Cross-references
Synonyms
- CP-533,536
- CP-533536
- 2-(3-((((4-(1,1-dimethylethyl)phenyl)methyl)(pyridin-3-ylsulfonyl)amino)methyl)phenoxy)acetic acid
- 2-[3-[[pyridin-3-ylsulfonyl-[(4-tert-butylphenyl)methyl]amino]methyl]phenoxy]acetic Acid
- CP533536
- L266R6E31E
- evatanepagum
- RefChem:921400
- CP-533536 free acid
- MFCD09833940
- Evatanepag [USAN:INN]
- UNII-L266R6E31E
- EVATANEPAG [INN]
- Evatanepag (USAN/INN)
- EVATANEPAG [USAN]
- EVATANEPAG [WHO-DD]
- SCHEMBL533264
- GTPL1929
- orb1308320
- Evatanepag (CP-533536)?
- SCHEMBL29376960
- C25H28N2O5S
- CHEBI:177472
- WOHRHWDYFNWPNG-UHFFFAOYSA-N
- EX-A2354
- Evatanepag; CP-533536 free acid
- BDBM50293496
- AKOS030526731
- CS-5571
- AC-33701
- BS-51414
- CJ042794
- DA-73265
- FT145127
- HY-14839
- SY263729
- NS00068508
- D09613
- N16936
Look up EVATANEPAG in the interactive SynDRA portal →